Bcl-2 inhibitor - Google News

Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting - Marketscreener.com

over 4 years ago

STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO FUND TARGETED CANCER THERAPY RESEARCH - StreetInsider.com

over 4 years ago

STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO...

Evaluating Fixed-Duration Ibrutinib and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia - DocWire News

over 4 years ago

Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for Pirtobrutinib at the American Society of Hematology Annual Meeting - Yahoo Finance

almost 5 years ago

Clinical Challenges: Treatment Options in Waldenström Macroglobulinemia - Medpage Today

almost 5 years ago

Clinical Challenges: Optimizing CLL Treatment | MedPage Today - Medpage Today

almost 5 years ago

Ascentage Pharma Presented at the 40th Annual JP Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma - PR Newswire

over 4 years ago

Roundtable Discussion: Pagel Walks Through Treatment Choices in Chronic Lymphocytic Leukemia - Targeted Oncology

over 4 years ago

Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell ... - KULR-TV

over 4 years ago

Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell...

Biopharma Companies Line Up Presentations Ahead of AACR Oncology Conference - BioSpace

over 4 years ago

Biopharma Companies Line Up Presentations Ahead of AACR Oncology Conference  BioSpace

BIO-PATH HOLDINGS REPORTS FULL YEAR 2021 FINANCIAL RESULTS - Marketscreener.com

over 4 years ago

BIO-PATH HOLDINGS REPORTS FULL YEAR 2021 FINANCIAL RESULTS  Marketscreener.com

Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials - what's up

over 4 years ago

Mays Cancer Center researcher and SignalRx earn NCI business grants to develop...